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CT  of  acute  pancreatitis:  A  matter  of  time
In  this  issue  of  Diagnostic  and  Interventional  Imaging,  Türkvatan  and  colleagues  present  a
nice  overview  of  the  computed  tomography  (CT)  features  of  acute  pancreatitis  (AP)  and  its
potential  complications  [1,2].  There  is  currently  no  doubt  upon  the  fact  that  CT  is  the  key
imaging  test  in  the  area  of  AP.  This  is  supported  by  a  tremendous  amount  of  data  from  the
scientiﬁc  medical  literature  [3—14].  In  this  regard,  the  CT  severity  index  (CTSI)  is  regarded
as  a  strong  predictor  of  the  mortality  in  patients  with  AP  [6,7,10].However,  the  positive  diagnosis  of  AP  is  based  on  the  presence  of  two  variables  among
the  following  three:  a  suggestive  upper  abdominal  pain,  a serum  amylase  and/or  lipase
greater  than  3  times  the  upper  limit  of  normal  value,  and  typical  CT  ﬁndings  of  AP  [3,11].
And  we  must  admit  that  in  an  emergency  setting,  the  diagnosis  of  AP  is  most  often  based
on  the  ﬁrst  two  variables  because  patients  with  AP  often  undergo  CT  examination  later
after  admission  or  after  the  onset  of  symptoms.  One  reason  for  a  delayed  CT  examination
is  that  CT  is  not  obtainable  right  away  in  many  busy  departments  of  radiology.  The  other
reason  is  that  international  guidelines  advocate  performing  CT  examination  at  least  72  to
96  hours  after  the  onset  of  symptoms  [3]. Nonetheless,  this  recommendation  is  not  based
on  strong  evidence.
In  the  era  of  the  dictatorship  of  the  ‘‘evidence-based  medicine’’,  it  is  surprising  or  even
irritating  that  such  a  time  interval  for  CT  be  not  based  on  strong  scientiﬁc  data.  A  careful
analysis  of  the  existing  literature  does  not  provide  strong  evidence  for  a speciﬁc  delay
between  the  onset  of  symptoms  and  CT  examination.  In  the  early  study  by  Balthazar  et  al.,
CT  examinations  were  performed  between  1  to  10  days  following  the  onset  of  symptoms
and  only  40/83  (48%)  patients  had  CT  examinations  within  the  ﬁrst  72  hours  [12]. Other
researchers  agree  upon  the  fact  that  CT  should  be  performed  within  the  72  ﬁrst  hours
following  the  onset  of  symptoms  of  AP  [6]  but  none  ﬁrmly  states  that  CT  examination
should  be  performed  at  72  hours  or  after  72  hours.  Moreover,  other  groups  performed  CT
examinations  within  the  48  hours  following  admission  or  the  onset  of  symptoms  [5,15,16]
and  not  at  48  hours  whereas  others  performed  CT  within  one  day  [14,17].  Because  of
discordant  scenarios,  it  is  difﬁcult  to  propose  a  deﬁnite  optimal  time  interval  for  CT.
We  do  believe  that  the  issue  of  timely  application  of  CT  examination  in  patients  with
AP  is  not  fully  addressed  by  the  existing  literature.  Conversely,  what  is  well  acknowledged
for  sure  is  that  the  two  most  important  indicators  of  severity  of  AP  are  organ  failure
(particularly  multisystem  organ  failure)  and  pancreatic  necrosis.  The  other  point  that  is  not
debated  is  that  patients  with  AP  should  receive  the  best  possible  care.  Best  management
of  patients  with  AP  requires  knowing  the  degree  of  severity  of  AP,  anticipating  potential
severe  complications  and  referring  the  patient  to  the  most  appropriate  structure  of  care.
In  this  regard,  contrast-enhanced  CT  is  currently  the  reference  standard  to  discriminate
between  interstitial  AP  that  requires  medical  management  and  necrotizing  AP  that  requires
referral  to  an  intensive  care  unit.  In  addition,  it  is  currently  well  admitted  that  patients
with  gallstone-associated  AP  should  undergo  cholecystectomy  to  avoid  recurrence  [3].
http://dx.doi.org/10.1016/j.diii.2015.01.001
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owever,  again  CT  is  the  cornerstone  of  an  appropriate
anagement  because  cholecystectomy  should  be  performed
ithout  any  delay,  and  preferably  within  the  ﬁrst  24  hours
f  admission,  in  patients  who  have  mild  AP  and  ideally
uring  the  same  hospital  stay  [18].  Conversely,  in  patients
ith  severe  gallstone-related  AP,  cholecystectomy  should  be
elayed  until  substantial  resolution  of  the  inﬂammatory  pro-
ess  and  clinical  recovery.  Consequently,  in  this  latter  group
f  patients,  CT  should  be  performed  as  soon  as  possible
or  deciding  on  the  best  management  option  and  possibly
ending  the  patient  to  surgery.
Another  reason  for  early  CT  is  that  it  is  difﬁcult  to  antic-
pate  the  course  of  AP  in  a  given  patient,  especially  in  older
atients  and  in  those  who  have  associated  comorbidities.
n  a  recent  study,  CT  helped  heighten  conﬁdence  in  the
iagnosis  of  AP  compared  to  the  results  of  clinical  and  bio-
ogical  examinations  and  showed  remarkable  performance
n  predicting  patient  outcome  [4].  The  same  study  showed
hat  morphologic  features  on  early  CT  are  independent  and
trong  predictors  of  outcome  in  patients  with  severe  AP  [4].
ore  speciﬁcally,  imaging  features  were  strong  predictors
f  infection,  and  patients  at  increased  risk  for  infection  had
ore  aggressive  monitoring  and  treatment  [4].
In  their  papers,  Türkvatan  et  al.  have  addressed  the  role
f  MR  imaging  for  the  diagnosis  of  AP  [1,2].  So  far,  several
tudies  have  showed  that  MR  imaging  is  a  useful  tool  for  the
iagnosis  of  AP  and  is  equivalent  to  [19,20]  or  even  surpasses
T  [8]  for  evaluating  the  severity  of  the  disease.  Because  of
ecent  improvements  in  MR  imaging  in  the  ﬁeld  of  pancreatic
isease,  further  studies  should  be  performed  to  determine
o  what  extent  MR  imaging  could  implement  CT  in  patients
ith  AP  [21,22].
In  conclusion,  we  do  believe  that  AP  is  a  serious  disease
hat  needs  early  CT  for  best  management.  In  a  recent  analy-
is  about  daily  practice  in  the  US,  the  authors  observed  that
6%  of  patients  with  AP  underwent  CT  examination  upon
dmission  (i.e.,  within  24  h),  which  is  far  from  the  ofﬁcial
uidelines  [23].  But  this  picture  reﬂects  what  is  actually
one  at  many  institutions.  We  thus  suggest  that  one  should
ollow  these  ‘‘daily  practice-based’’  guidelines  for  better
are.
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